Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...

The US regulator has asked for a second phase 3 study on Santhera’s Duchenne muscular dystrophy (DMD) drug Raxone (idebenone), delaying possible approval by several years and sending the Swiss ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Evaxion Biotech (EVAX – Research Report) and ...

Santhera Pharmaceuticals will launch its new drug for Duchenne muscular dystrophy in the UK within the next few weeks, after getting confirmation it will be covered by the NHS in all four nations.

Cumberland Pharmaceuticals’ Duchenne muscular dystrophy (DMD) drug has improved the amount of blood pumped by the heart, ...

At close: February 6 at 3:00:00 PM EST ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Agreement drives continued patient access to four important therapies in Japan and Korea Strengthens Essential Pharma and Clinigen's combined market presence in the JAPAC region Egham, UK - 6th ...

HITC Healthcare Integrated Technologies, Inc.